3DPTEK closes multimillion-yuan Series B round led by CICC Capital

2020-07-03
|
Isiah Liu

3DPTEK closes multimillion-yuan Series B round led by CICC Capital

3DPTEK, a high-tech company primarily engaged in the field of 3D printing (additive manufacturing), announced on July 2 the completion of tens of millions of yuan in a Series B financing round led by the state-owned CICC Capital, with participation from Nanning High-tech Industrial Fund and Xizi Capital.


Proceeds from the latest financing round will be used to expand the company's scale-up of 3D printing applications, acquire medical device qualifications for 3D printing rehabilitation medical-related projects, and improve the speed of delivery of 3D printing cloud manufacturing services.


3DPTEK is a manufacturer of 3D printers and service provider for the 3D printing sector. The company develops 3D printing equipments and provide 3D printing services that serve the aerospace, automotive, education and medical fields.


Zong Guisheng, founder and chairman of 3DPTEK, said: "Our team has filed more than 220 patents in the field of 3D printing, of which more than 90 are invention patents. Our extensive experience in the industry , and clear and robust development model are our unique advantages.”


RELATED ARTICLES

Eugenlight Technologies closes Series A of RMB tens of millions
2020-09-13
|
PEVC , Semiconductor , Electroinic

BPassword closes angel round led by Eagle Fund
2020-09-13
|
PEVC , Blockchain

Microtera Semiconductor closes Series A with RMB tens of millions
2020-09-13
|
PEVC , Semiconductor

Vertex Ventures completes new fund raising of RMB three bln
2020-09-13
|
PEVC , Technology , Semiconductor

Xiaoyinghe closes seed round of two mln yuan
2020-09-12
|
PEVC , Internet

Tingyun closes Series C of RMB 400 mln
2020-09-12
|
PEVC

Vision Medicals closes RMB200m Series B led by CDH Investments
2020-08-14
|
PEVC , Medicine , Medical care

Thousand Oaks Biopharmaceuticals closes RMB450m Series B round
2020-07-28
|
Biotech , Pharmaceutical , PEVC

HaiHe Biopharma closes RMB1.2b Series B led by Warburg Pincus
2020-07-27
|
Biotech , PEVC , Pharmaceutical
China SDG